
DX3-213B
CAS No. 2749555-66-4
DX3-213B( —— )
Catalog No. M35700 CAS No. 2749555-66-4
DX3-213B is a potent, orally active inhibitor of oxidative phosphorylation (OXPHOS) complex I with an IC50 of 3.6 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 112 | Get Quote |
![]() ![]() |
5MG | 170 | Get Quote |
![]() ![]() |
10MG | 275 | Get Quote |
![]() ![]() |
25MG | 569 | Get Quote |
![]() ![]() |
50MG | 824 | Get Quote |
![]() ![]() |
100MG | 1098 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameDX3-213B
-
NoteResearch use only, not for human use.
-
Brief DescriptionDX3-213B is a potent, orally active inhibitor of oxidative phosphorylation (OXPHOS) complex I with an IC50 of 3.6 nM.
-
DescriptionDX3-213B is a highly potent, orally active oxidative phosphorylation (OXPHOS) complex I inhibitor (IC50=3.6 nM). DX3-213B impairs ATP generation (IC50=11 nM), and blocks MIA PaCa-2 cell growth (GI50=11 nM). DX3-213B is used for the research of the pancreatic cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOXPHOS
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2749555-66-4
-
Formula Weight478.57
-
Molecular FormulaC20H28F2N2O5S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (261.19 mM; Ultrasonic (<60°C)
-
SMILESCC(C)S(=O)(=O)c1ccc(cc1)S(=O)(=O)N1CCC[C@H](C1)C(=O)N1CCC(F)(F)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xue D, et al. Multiparameter Optimization of Oxidative Phosphorylation Inhibitors for the Treatment of Pancreatic Cancer. J Med Chem. 2022;65(4):3404-3419. ?
molnova catalog



related products
-
ELA-21 (human)
High affinity apelin receptor agonist. Binds apelin receptors in left ventricle from normal and pulmonary arterial hypertensive (PAH) hearts (pKi values are 9.31 and 9.46, respectively). Bioactive fragment of ELA-32. Inhibits forskolin-induced cAMP production and stimulates β-arrestin recruitment in vitro.
-
Pilosidine
Pilosidine has vasoconstrictor activity, it showed facilitating effect on adrenaline evoked contractions in rabbit aorta isolated preparations.
-
ML390
ML390 exerts its potent differentiation effect on multiple leukemia models.